img

Global Canine Arthritis Treatment Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Canine Arthritis Treatment Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

The canine arthritis treatment types include non-steroidal anti-inflammatory medications (NSAIDs), opioids and stem cell Canine Arthritis Treatment. Non-steroidal anti-inflammatory Canine Arthritis Treatment are used to control pain and inflammation associated with arthritis. They are most commonly used canine arthritis treatment drugs. NSAIDs are used to treat mild to moderate pain by reducing the production of prostaglandins, which is involved with inflammation and discomfort. Several non-steroidal anti-inflammatory medications approved for canine arthritis treatment are Ketaprofen, Carprofen, Deracoxib, and Rimadyl, among others. Opioids are another class of pain relief medication for canine arthritis treatment, which includes Tramadol, Tapentadol, and buprenorphine, among others. Opioids work by acting through the central opioid receptors. They are used to treat moderate to severe as well as chronic pain associated with arthritis. The stem cell therapy is a new treatment option for canine arthritis treatment. The stem cell Canine Arthritis Treatment is usually performed as canine arthritis treatment using either autologous stem cells or allogeneic stem cells Canine Arthritis Treatment. In the stem cell canine arthritis treatment, the adult stem cells are harvested from canine’s fat tissues and injected into the affected joints. The stem cell Canine Arthritis Treatment has improved the quality of life of canines by reducing pain and increasing mobility and has shown 85% success rate within 5 months of canine arthritis treatment.
Canine Arthritis Treatment report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Canine Arthritis Treatment market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Demand from Veterinary Hospitals and Clinics and Drug Stores are the major drivers for the industry.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Canine Arthritis Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Elanco (Eli Lilly and Company)
Boehringer Ingelheim
Zoetis Inc
Vetoquinol S.A.
Bayer AG
Aratana Therapeutics Inc
Norbrook Laboratories Limited
VetStem Biopharma
Dechra Pharmaceuticals Plc
Segment by Type
Non-Steroidal Anti-Inflammatory Drugs
Opioids

Segment by Application


Veterinary Hospitals and Clinics
Drug Stores
E-commerce
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Canine Arthritis Treatment market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Canine Arthritis Treatment introduction, etc. Canine Arthritis Treatment Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Canine Arthritis Treatment market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.

Table of Content

1 Market Overview of Canine Arthritis Treatment
1.1 Canine Arthritis Treatment Market Overview
1.1.1 Canine Arthritis Treatment Product Scope
1.1.2 Canine Arthritis Treatment Market Status and Outlook
1.2 Global Canine Arthritis Treatment Market Size Overview by Region 2018 VS 2022 VS 2033
1.3 Global Canine Arthritis Treatment Market Size by Region (2018-2033)
1.4 Global Canine Arthritis Treatment Historic Market Size by Region (2018-2023)
1.5 Global Canine Arthritis Treatment Market Size Forecast by Region (2024-2033)
1.6 Key Regions, Canine Arthritis Treatment Market Size (2018-2033)
1.6.1 North America Canine Arthritis Treatment Market Size (2018-2033)
1.6.2 Europe Canine Arthritis Treatment Market Size (2018-2033)
1.6.3 Asia-Pacific Canine Arthritis Treatment Market Size (2018-2033)
1.6.4 Latin America Canine Arthritis Treatment Market Size (2018-2033)
1.6.5 Middle East & Africa Canine Arthritis Treatment Market Size (2018-2033)
2 Canine Arthritis Treatment Market by Type
2.1 Introduction
2.1.1 Non-Steroidal Anti-Inflammatory Drugs
2.1.2 Opioids
2.2 Global Canine Arthritis Treatment Market Size by Type: 2018 VS 2022 VS 2033
2.2.1 Global Canine Arthritis Treatment Historic Market Size by Type (2018-2023)
2.2.2 Global Canine Arthritis Treatment Forecasted Market Size by Type (2024-2033)
2.3 Key Regions Market Size by Type
2.3.1 North America Canine Arthritis Treatment Revenue Breakdown by Type (2018-2033)
2.3.2 Europe Canine Arthritis Treatment Revenue Breakdown by Type (2018-2033)
2.3.3 Asia-Pacific Canine Arthritis Treatment Revenue Breakdown by Type (2018-2033)
2.3.4 Latin America Canine Arthritis Treatment Revenue Breakdown by Type (2018-2033)
2.3.5 Middle East and Africa Canine Arthritis Treatment Revenue Breakdown by Type (2018-2033)
3 Canine Arthritis Treatment Market Overview by Application
3.1 Introduction
3.1.1 Veterinary Hospitals and Clinics
3.1.2 Drug Stores
3.1.3 E-commerce
3.2 Global Canine Arthritis Treatment Market Size by Application: 2018 VS 2022 VS 2033
3.2.1 Global Canine Arthritis Treatment Historic Market Size by Application (2018-2023)
3.2.2 Global Canine Arthritis Treatment Forecasted Market Size by Application (2024-2033)
3.3 Key Regions Market Size by Application
3.3.1 North America Canine Arthritis Treatment Revenue Breakdown by Application (2018-2033)
3.3.2 Europe Canine Arthritis Treatment Revenue Breakdown by Application (2018-2033)
3.3.3 Asia-Pacific Canine Arthritis Treatment Revenue Breakdown by Application (2018-2033)
3.3.4 Latin America Canine Arthritis Treatment Revenue Breakdown by Application (2018-2033)
3.3.5 Middle East and Africa Canine Arthritis Treatment Revenue Breakdown by Application (2018-2033)
4 Canine Arthritis Treatment Competition Analysis by Players
4.1 Global Canine Arthritis Treatment Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Canine Arthritis Treatment as of 2022)
4.3 Date of Key Players Enter into Canine Arthritis Treatment Market
4.4 Global Top Players Canine Arthritis Treatment Headquarters and Area Served
4.5 Key Players Canine Arthritis Treatment Product Solution and Service
4.6 Competitive Status
4.6.1 Canine Arthritis Treatment Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Elanco (Eli Lilly and Company)
5.1.1 Elanco (Eli Lilly and Company) Profile
5.1.2 Elanco (Eli Lilly and Company) Main Business
5.1.3 Elanco (Eli Lilly and Company) Canine Arthritis Treatment Products, Services and Solutions
5.1.4 Elanco (Eli Lilly and Company) Canine Arthritis Treatment Revenue (US$ Million) & (2018-2023)
5.1.5 Elanco (Eli Lilly and Company) Recent Developments
5.2 Boehringer Ingelheim
5.2.1 Boehringer Ingelheim Profile
5.2.2 Boehringer Ingelheim Main Business
5.2.3 Boehringer Ingelheim Canine Arthritis Treatment Products, Services and Solutions
5.2.4 Boehringer Ingelheim Canine Arthritis Treatment Revenue (US$ Million) & (2018-2023)
5.2.5 Boehringer Ingelheim Recent Developments
5.3 Zoetis Inc
5.3.1 Zoetis Inc Profile
5.3.2 Zoetis Inc Main Business
5.3.3 Zoetis Inc Canine Arthritis Treatment Products, Services and Solutions
5.3.4 Zoetis Inc Canine Arthritis Treatment Revenue (US$ Million) & (2018-2023)
5.3.5 Vetoquinol S.A. Recent Developments
5.4 Vetoquinol S.A.
5.4.1 Vetoquinol S.A. Profile
5.4.2 Vetoquinol S.A. Main Business
5.4.3 Vetoquinol S.A. Canine Arthritis Treatment Products, Services and Solutions
5.4.4 Vetoquinol S.A. Canine Arthritis Treatment Revenue (US$ Million) & (2018-2023)
5.4.5 Vetoquinol S.A. Recent Developments
5.5 Bayer AG
5.5.1 Bayer AG Profile
5.5.2 Bayer AG Main Business
5.5.3 Bayer AG Canine Arthritis Treatment Products, Services and Solutions
5.5.4 Bayer AG Canine Arthritis Treatment Revenue (US$ Million) & (2018-2023)
5.5.5 Bayer AG Recent Developments
5.6 Aratana Therapeutics Inc
5.6.1 Aratana Therapeutics Inc Profile
5.6.2 Aratana Therapeutics Inc Main Business
5.6.3 Aratana Therapeutics Inc Canine Arthritis Treatment Products, Services and Solutions
5.6.4 Aratana Therapeutics Inc Canine Arthritis Treatment Revenue (US$ Million) & (2018-2023)
5.6.5 Aratana Therapeutics Inc Recent Developments
5.7 Norbrook Laboratories Limited
5.7.1 Norbrook Laboratories Limited Profile
5.7.2 Norbrook Laboratories Limited Main Business
5.7.3 Norbrook Laboratories Limited Canine Arthritis Treatment Products, Services and Solutions
5.7.4 Norbrook Laboratories Limited Canine Arthritis Treatment Revenue (US$ Million) & (2018-2023)
5.7.5 Norbrook Laboratories Limited Recent Developments
5.8 VetStem Biopharma
5.8.1 VetStem Biopharma Profile
5.8.2 VetStem Biopharma Main Business
5.8.3 VetStem Biopharma Canine Arthritis Treatment Products, Services and Solutions
5.8.4 VetStem Biopharma Canine Arthritis Treatment Revenue (US$ Million) & (2018-2023)
5.8.5 VetStem Biopharma Recent Developments
5.9 Dechra Pharmaceuticals Plc
5.9.1 Dechra Pharmaceuticals Plc Profile
5.9.2 Dechra Pharmaceuticals Plc Main Business
5.9.3 Dechra Pharmaceuticals Plc Canine Arthritis Treatment Products, Services and Solutions
5.9.4 Dechra Pharmaceuticals Plc Canine Arthritis Treatment Revenue (US$ Million) & (2018-2023)
5.9.5 Dechra Pharmaceuticals Plc Recent Developments
6 North America
6.1 North America Canine Arthritis Treatment Market Size by Country (2018-2033)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Canine Arthritis Treatment Market Size by Country (2018-2033)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Canine Arthritis Treatment Market Size by Region (2018-2033)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Canine Arthritis Treatment Market Size by Country (2018-2033)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Canine Arthritis Treatment Market Size by Country (2018-2033)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Canine Arthritis Treatment Market Dynamics
11.1 Canine Arthritis Treatment Industry Trends
11.2 Canine Arthritis Treatment Market Drivers
11.3 Canine Arthritis Treatment Market Challenges
11.4 Canine Arthritis Treatment Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Canine Arthritis Treatment Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2033
Table 2. Global Canine Arthritis Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 3. Global Canine Arthritis Treatment Market Size Share by Region (2018-2023)
Table 4. Global Canine Arthritis Treatment Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 5. Global Canine Arthritis Treatment Forecasted Market Size Share by Region (2024-2033)
Table 6. Global Canine Arthritis Treatment Market Size (US$ Million) by Type: 2018 VS 2022 VS 2033
Table 7. Global Canine Arthritis Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 8. Global Canine Arthritis Treatment Revenue Market Share by Type (2018-2023)
Table 9. Global Canine Arthritis Treatment Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 10. Global Canine Arthritis Treatment Revenue Market Share by Type (2024-2033)
Table 11. North America Canine Arthritis Treatment Revenue by Type (2018-2023) & (US$ Million)
Table 12. North America Canine Arthritis Treatment Revenue by Type (2024-2033) & (US$ Million)
Table 13. Europe Canine Arthritis Treatment Revenue by Type (2018-2023) & (US$ Million)
Table 14. Europe Canine Arthritis Treatment Revenue by Type (2024-2033) & (US$ Million)
Table 15. Asia-Pacific Canine Arthritis Treatment Revenue by Type (2018-2023) & (US$ Million)
Table 16. Asia-Pacific Canine Arthritis Treatment Revenue by Type (2024-2033) & (US$ Million)
Table 17. Latin America Canine Arthritis Treatment Revenue by Type (2018-2023) & (US$ Million)
Table 18. Latin America Canine Arthritis Treatment Revenue by Type (2024-2033) & (US$ Million)
Table 19. Middle East and Africa Canine Arthritis Treatment Revenue by Type (2018-2023) & (US$ Million)
Table 20. Middle East and Africa Canine Arthritis Treatment Revenue by Type (2024-2033) & (US$ Million)
Table 21. Global Canine Arthritis Treatment Market Size (US$ Million) by Application: 2018 VS 2022 VS 2033
Table 22. Global Canine Arthritis Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 23. Global Canine Arthritis Treatment Revenue Market Share by Application (2018-2023)
Table 24. Global Canine Arthritis Treatment Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 25. Global Canine Arthritis Treatment Revenue Market Share by Application (2024-2033)
Table 26. North America Canine Arthritis Treatment Revenue by Application (2018-2023) & (US$ Million)
Table 27. North America Canine Arthritis Treatment Revenue by Application (2024-2033) & (US$ Million)
Table 28. Europe Canine Arthritis Treatment Revenue by Application (2018-2023) & (US$ Million)
Table 29. Europe Canine Arthritis Treatment Revenue by Application (2024-2033) & (US$ Million)
Table 30. Asia-Pacific Canine Arthritis Treatment Revenue by Application (2018-2023) & (US$ Million)
Table 31. Asia-Pacific Canine Arthritis Treatment Revenue by Application (2024-2033) & (US$ Million)
Table 32. Latin America Canine Arthritis Treatment Revenue by Application (2018-2023) & (US$ Million)
Table 33. Latin America Canine Arthritis Treatment Revenue by Application (2024-2033) & (US$ Million)
Table 34. Middle East and Africa Canine Arthritis Treatment Revenue by Application (2018-2023) & (US$ Million)
Table 35. Middle East and Africa Canine Arthritis Treatment Revenue by Application (2024-2033) & (US$ Million)
Table 36. Global Canine Arthritis Treatment Revenue (US$ Million) by Players (2018-2023)
Table 37. Global Canine Arthritis Treatment Revenue Market Share by Players (2018-2023)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Canine Arthritis Treatment as of 2022)
Table 39. Date of Key Players Enter into Canine Arthritis Treatment Market
Table 40. Global Canine Arthritis Treatment Key Players Headquarters and Area Served
Table 41. Canine Arthritis Treatment Product Solution and Service
Table 42. Global Canine Arthritis Treatment Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Elanco (Eli Lilly and Company) Basic Information List
Table 45. Elanco (Eli Lilly and Company) Description and Business Overview
Table 46. Elanco (Eli Lilly and Company) Canine Arthritis Treatment Products, Services and Solutions
Table 47. Revenue (US$ Million) in Canine Arthritis Treatment Business of Elanco (Eli Lilly and Company) (2018-2023)
Table 48. Elanco (Eli Lilly and Company) Recent Developments
Table 49. Boehringer Ingelheim Basic Information List
Table 50. Boehringer Ingelheim Description and Business Overview
Table 51. Boehringer Ingelheim Canine Arthritis Treatment Products, Services and Solutions
Table 52. Revenue (US$ Million) in Canine Arthritis Treatment Business of Boehringer Ingelheim (2018-2023)
Table 53. Boehringer Ingelheim Recent Developments
Table 54. Zoetis Inc Basic Information List
Table 55. Zoetis Inc Description and Business Overview
Table 56. Zoetis Inc Canine Arthritis Treatment Products, Services and Solutions
Table 57. Revenue (US$ Million) in Canine Arthritis Treatment Business of Zoetis Inc (2018-2023)
Table 58. Zoetis Inc Recent Developments
Table 59. Vetoquinol S.A. Basic Information List
Table 60. Vetoquinol S.A. Description and Business Overview
Table 61. Vetoquinol S.A. Canine Arthritis Treatment Products, Services and Solutions
Table 62. Revenue (US$ Million) in Canine Arthritis Treatment Business of Vetoquinol S.A. (2018-2023)
Table 63. Vetoquinol S.A. Recent Developments
Table 64. Bayer AG Basic Information List
Table 65. Bayer AG Description and Business Overview
Table 66. Bayer AG Canine Arthritis Treatment Products, Services and Solutions
Table 67. Revenue (US$ Million) in Canine Arthritis Treatment Business of Bayer AG (2018-2023)
Table 68. Bayer AG Recent Developments
Table 69. Aratana Therapeutics Inc Basic Information List
Table 70. Aratana Therapeutics Inc Description and Business Overview
Table 71. Aratana Therapeutics Inc Canine Arthritis Treatment Products, Services and Solutions
Table 72. Revenue (US$ Million) in Canine Arthritis Treatment Business of Aratana Therapeutics Inc (2018-2023)
Table 73. Aratana Therapeutics Inc Recent Developments
Table 74. Norbrook Laboratories Limited Basic Information List
Table 75. Norbrook Laboratories Limited Description and Business Overview
Table 76. Norbrook Laboratories Limited Canine Arthritis Treatment Products, Services and Solutions
Table 77. Revenue (US$ Million) in Canine Arthritis Treatment Business of Norbrook Laboratories Limited (2018-2023)
Table 78. Norbrook Laboratories Limited Recent Developments
Table 79. VetStem Biopharma Basic Information List
Table 80. VetStem Biopharma Description and Business Overview
Table 81. VetStem Biopharma Canine Arthritis Treatment Products, Services and Solutions
Table 82. Revenue (US$ Million) in Canine Arthritis Treatment Business of VetStem Biopharma (2018-2023)
Table 83. VetStem Biopharma Recent Developments
Table 84. Dechra Pharmaceuticals Plc Basic Information List
Table 85. Dechra Pharmaceuticals Plc Description and Business Overview
Table 86. Dechra Pharmaceuticals Plc Canine Arthritis Treatment Products, Services and Solutions
Table 87. Revenue (US$ Million) in Canine Arthritis Treatment Business of Dechra Pharmaceuticals Plc (2018-2023)
Table 88. Dechra Pharmaceuticals Plc Recent Developments
Table 89. North America Canine Arthritis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 90. North America Canine Arthritis Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 91. Europe Canine Arthritis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 92. Europe Canine Arthritis Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 93. Asia-Pacific Canine Arthritis Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 94. Asia-Pacific Canine Arthritis Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 95. Asia-Pacific Canine Arthritis Treatment Market Size by Region (2024-2033) & (US$ Million)
Table 96. Asia-Pacific Canine Arthritis Treatment Market Share by Region (2018-2023)
Table 97. Asia-Pacific Canine Arthritis Treatment Market Share by Region (2024-2033)
Table 98. Latin America Canine Arthritis Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 99. Latin America Canine Arthritis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 100. Latin America Canine Arthritis Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 101. Middle East & Africa Canine Arthritis Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 102. Middle East & Africa Canine Arthritis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 103. Middle East & Africa Canine Arthritis Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 104. Canine Arthritis Treatment Market Trends
Table 105. Canine Arthritis Treatment Market Drivers
Table 106. Canine Arthritis Treatment Market Challenges
Table 107. Canine Arthritis Treatment Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Canine Arthritis Treatment Market Size Year-over-Year 2018-2033 & (US$ Million)
Figure 2. Global Canine Arthritis Treatment Market Size (US$ Million), 2018 VS 2022 VS 2033
Figure 3. Global Canine Arthritis Treatment Market Share by Regions: 2022 VS 2033
Figure 4. Global Canine Arthritis Treatment Forecasted Market Size Share by Region (2024-2033)
Figure 5. North America Canine Arthritis Treatment Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 6. Europe Canine Arthritis Treatment Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 7. Asia-Pacific Canine Arthritis Treatment Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 8. Latin America Canine Arthritis Treatment Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 9. Middle East & Africa Canine Arthritis Treatment Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 10. Product Picture of Non-Steroidal Anti-Inflammatory Drugs
Figure 11. Global Non-Steroidal Anti-Inflammatory Drugs Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 12. Product Picture of Opioids
Figure 13. Global Opioids Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 14. Global Canine Arthritis Treatment Market Size Share by Type: 2022 & 2033
Figure 15. North America Canine Arthritis Treatment Revenue Market Share by Type (2018-2033)
Figure 16. Europe Canine Arthritis Treatment Revenue Market Share by Type (2018-2033)
Figure 17. Asia-Pacific Canine Arthritis Treatment Revenue Market Share by Type (2018-2033)
Figure 18. Latin America Canine Arthritis Treatment Revenue Market Share by Type (2018-2033)
Figure 19. Middle East and Africa Canine Arthritis Treatment Revenue Market Share by Type (2018-2033)
Figure 20. Veterinary Hospitals and Clinics Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 21. Drug Stores Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 22. E-commerce Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 23. Global Canine Arthritis Treatment Market Size Share by Application: 2022 & 2033
Figure 24. North America Canine Arthritis Treatment Revenue Market Share by Application (2018-2033)
Figure 25. Europe Canine Arthritis Treatment Revenue Market Share by Application (2018-2033)
Figure 26. Asia-Pacific Canine Arthritis Treatment Revenue Market Share by Application (2018-2033)
Figure 27. Latin America Canine Arthritis Treatment Revenue Market Share by Application (2018-2033)
Figure 28. Middle East and Africa Canine Arthritis Treatment Revenue Market Share by Application (2018-2033)
Figure 29. Canine Arthritis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 30. Global Top 5 and Top 10 Players Canine Arthritis Treatment Market Share in 2022
Figure 31. North America Canine Arthritis Treatment Market Share by Country (2018-2033)
Figure 32. United States Canine Arthritis Treatment Market Size (2018-2033) & (US$ Million)
Figure 33. Canada Canine Arthritis Treatment Market Size (2018-2033) & (US$ Million)
Figure 34. Germany Canine Arthritis Treatment Market Size (2018-2033) & (US$ Million)
Figure 35. France Canine Arthritis Treatment Market Size (2018-2033) & (US$ Million)
Figure 36. U.K. Canine Arthritis Treatment Market Size (2018-2033) & (US$ Million)
Figure 37. Italy Canine Arthritis Treatment Market Size (2018-2033) & (US$ Million)
Figure 38. Russia Canine Arthritis Treatment Market Size (2018-2033) & (US$ Million)
Figure 39. Nordic Countries Canine Arthritis Treatment Market Size (2018-2033) & (US$ Million)
Figure 40. Asia-Pacific Canine Arthritis Treatment Market Share by Region (2018-2033)
Figure 41. China Canine Arthritis Treatment Market Size (2018-2033) & (US$ Million)
Figure 42. Japan Canine Arthritis Treatment Market Size (2018-2033) & (US$ Million)
Figure 43. South Korea Canine Arthritis Treatment Market Size (2018-2033) & (US$ Million)
Figure 44. Southeast Asia Canine Arthritis Treatment Market Size (2018-2033) & (US$ Million)
Figure 45. India Canine Arthritis Treatment Market Size (2018-2033) & (US$ Million)
Figure 46. Australia Canine Arthritis Treatment Market Size (2018-2033) & (US$ Million)
Figure 47. Latin America Canine Arthritis Treatment Market Share by Country (2018-2033)
Figure 48. Mexico Canine Arthritis Treatment Market Size (2018-2033) & (US$ Million)
Figure 49. Brazil Canine Arthritis Treatment Market Size (2018-2033) & (US$ Million)
Figure 50. Middle East & Africa Canine Arthritis Treatment Market Share by Country (2018-2033)
Figure 51. Turkey Canine Arthritis Treatment Market Size (2018-2033) & (US$ Million)
Figure 52. Saudi Arabia Canine Arthritis Treatment Market Size (2018-2033) & (US$ Million)
Figure 53. UAE Canine Arthritis Treatment Market Size (2018-2033) & (US$ Million)
Figure 54. Bottom-up and Top-down Approaches for This Report